119.90€
+
0.60€ (0.50%)
End-of-day quote: 05/07/2024
ENXTBR:UCB
UCB Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $777.77 | $636.99 | 0.00% | 9 | $690.32B |
| JNJ | Johnson & Johnson | NYSE | Outperform | $148.72 | $174.55 | 0.00% | 3 | $357.58B |
| MRK | Merck | NYSE | Outperform | $130.38 | $130.51 | 0.00% | 11 | $323.11B |
| ABBV | AbbVie | NYSE | Outperform | $162.55 | $178.42 | 0.00% | 11 | $287.36B |
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $572.87 | $591.94 | 0.00% | 1 | $218.93B |
| NOVN | Novartis | SWX | Hold | CHF89.78 | CHF105.00 | 0.00% | 9 | CHF179.76B |
| AMGN | Amgen | NasdaqGS | Outperform | $300.30 | $303.65 | 0.00% | 8 | $160.65B |
| SAN | Sanofi | ENXTPA | Outperform | 91.88€ | 102.80€ | 0.00% | 9 | 113.65€B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.04 | $58.15 | 0.00% | 10 | $88.99B |
| CSL | CSL | ASX | Outperform | $279.56 | $205.51 | 0.00% | 5 | $133.14B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $65.46 | $87.82 | 0.00% | 14 | $81.73B |
| SHW | Sherwin Williams | NYSE | Outperform | $318.75 | $317.38 | 0.00% | 9 | $79.90B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.10k | ¥4.74k | 0.00% | 0 | ¥6.47T |
| LONN | Lonza Group | SWX | Buy | CHF520.20 | CHF516.89 | 0.00% | 8 | CHF37.39B |
| PPG | PPG Industries | NYSE | Outperform | $134.21 | $159.04 | 0.00% | 1 | $31.31B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $13.95 | $11.59 | 0.00% | 9 | $15.92B |
| 4523 | Eisai | TSE | Outperform | ¥6.60k | ¥9.58k | 0.00% | 0 | ¥1.86T |
| INCY | Incyte | NasdaqGS | Outperform | $54.37 | $77.05 | 0.00% | 8 | $11.89B |
| CRDA | Croda International Plc | LSE | Outperform | £48.31 | £65.12 | 0.00% | 6 | £6.43B |
| APLS | Apellis Pharmaceuticals | NasdaqGS | Outperform | $43.90 | $79.81 | 0.00% | 3 | $5.59B |
| WCH | Wacker Chemie | XTRA | Outperform | 105.50€ | 145.36€ | 0.00% | 9 | 5.00€B |
| CLN | Clariant | SWX | Outperform | CHF14.39 | CHF16.11 | 0.00% | 6 | CHF4.53B |
| XFOR | X4 Pharmaceuticals | NasdaqCM | Outperform | $1.09 | $3.26 | 0.00% | 1 | $193.13M |
| OMER | Omeros | NasdaqGM | Hold | $3.64 | $13.00 | 0.00% | 2 | $182.52M |
| DXB | Dimerix | ASX | $0.35 | $0.00 | 0.00% | 0 | $159.38M | |
| BLRX | BioLineRx | TASE | - | ₪0.17 | ₪1.39 | 0.00% | 0 | ₪302.07M |
| IFRX | InflaRx N.V. | NasdaqGS | Outperform | $1.24 | $9.44 | 0.00% | 2 | $79.49M |
| AKTX | Akari Therapeutics, Plc | NasdaqCM | - | $1.45 | $80.00 | 0.00% | 0 | $9.39M |
